Ads
related to: fda approves- Dosing & Titration
Get Appropriate Dosing
for Patients. Learn More.
- Patient Brochure
Get Resources for Patients
Interested in this T2D Treatment
- Clinical Trial Results
Understand Clinical Trial Data
& Findings. Learn More on Site.
- Co-Pay Card
Cost Savings for Eligible Patients.
Learn More.
- Dosing & Titration
Search results
FDA Panel Rejects MDMA Drug for PTSD
Medscape· 14 hours agoA US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for ...
FDA Panel Rejects MDMA Therapy For PTSD, Citing Concerns Over Research Data In Setback For Advocates
Benzinga· 16 hours agoA committee of advisors to the U.S. Food and Drug Administration (FDA) dealt a blow to the...
FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD (NASDAQ:CMPS)
Seeking Alpha· 21 hours agoA panel of FDA advisors declined to endorse Lykos Therapeutics application for MDMA as a PTSD...
FDA panel rejects MDMA therapy for treating patients with PTSD
WSB Radio· 19 hours agoAn independent advisory panel of the Food and Drug Administration on Tuesday rejected the use of...
FDA advisers vote against first MDMA therapy to treat PTSD
CNN via Yahoo News· 20 hours agoA federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly...
Post-traumatic stress disorder: What to know as FDA weighs MDMA therapy
Washington Post· 12 hours agoThe U.S. Food and Drug Administration is deciding whether MDMA, a mind-altering compound better...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
AOL· 20 hours agoThe two votes — one for the treatment’s efficacy and one for its safety, by the agency’s Psychopharmacologic Drugs Advisory Committee — marked the first time that FDA advisers ...
Rebuke of psychedelic treatment explained
Politico· 5 hours agoThe FDA typically follows the advice of its advisers in deciding whether to approve a new treatment. The agency expects to decide on the drug therapy’s ...
Psychedelic-medicine stocks drop after ecstasy’s rocky day at the FDA
Market Watch· 6 hours agoPrivately held Lykos Therapeutics is seeking FDA approval for the treatment combining talk therapy...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
WLRN Miami· 20 hours agoIt represents a major setback for proponents of the drug and Lykos Therapeutics, which sponsored...
